Breaking News

You are here » Indian-Commodity  :  Top News  :  Glenmark Pharmaceuticals presents Phase 2a data on GBR 830

18-May2018

Glenmark Pharmaceuticals presents Phase 2a data on GBR 830

Glenmark Pharmaceuticals has presented new data from a Phase 2a, proof-of-concept study of GBR 830, an investigational, anti-OX40 monoclonal antibody being studied for the treatment of moderate-to-severe atopic dermatitis (AD), that were presented at the International Investigative Dermatology Meeting (IID) in Orlando, Florida. The exploratory Phase 2a study was conducted to investigate the safety of GBR 830, evaluate its effects on AD biomarkers, and generate the first clinical evidence of its biological activity.

Patients were randomized to receive two doses of GBR 830 or placebo, and were assessed for response at Day 29 and Day 71. New data from the study demonstrated that subsequent to treatment with GBR 830, epidermal hyperplasia, proliferation, and mRNA biomarkers for disease activity were reduced, indicating a possible effect on both the acute and chronic stages of AD.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).


Related News

View all news

Copper futures end higher on Tuesday

Copper futures ended higher on Tuesday after the United States and China announced fresh tariffs that were less harsh than some investors had feared. The US 10% tariff on $200 billion of Chinese imports......

Physical Rubber prices witness weakness on Tuesday

Physical Rubber prices showed weakness on Tuesday on account of buyer resistance in the market. Spot prices for RSS-4 variety fell to Rs 129.50/ kg compared to its previous closing of Rs 130/ kg; while......

Gold futures end lower with firm dollar

Gold futures ended lower on Tuesday, due to firm dollar after the Trump administration levied a 10% tariff on $200 billion in imported goods from China. Market players are on optimism that the impacts......

Top News

View all news

TI Financial Holdings to make investment of up to Rs 50 crore

TI Financial Holdings has received an approval for the further investment in shares of Cholamandalam Investment and Finance Company (CIFCL) up to 300,000 equity shares Rs 10 each, up to a sum not exceeding......

Glenmark Pharma inducts into Dow Jones Sustainability Indices 2018

Glenmark Pharmaceuticals has been listed on the Dow Jones Sustainability Indices 2018. Dow Jones Sustainability Index (DJSI) is one of the most esteemed global benchmarks for sustainable business practices.......

Tata Steel completes acquisition of 51% equity stake in CPDPL

Tata Steel has completed the acquisition of 51% equity stake in Creative Port Development (CPDPL). Earlier, the company had executed definitive agreement for development of Subarnarekha Port &......